⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EDIT News
Editas Medicine, Inc. Common Stock
Editas Medicine Announces Third Quarter 2025 Results and Business Updates
globenewswire.com
EDIT
Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025
globenewswire.com
EDIT
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
globenewswire.com
EDIT
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
globenewswire.com
EDIT